- Home
- SIEB vs CRBU Comparison
SIEB vs CRBU Comparison
Compare SIEB & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- CRBU
- Stock Information
- Founded
- SIEB 1886
- CRBU 2011
- Country
- SIEB United States
- CRBU United States
- Employees
- SIEB N/A
- CRBU N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- SIEB Finance
- CRBU Health Care
- Exchange
- SIEB Nasdaq
- CRBU Nasdaq
- Market Cap
- SIEB 95.1M
- CRBU 93.0M
- IPO Year
- SIEB N/A
- CRBU 2021
- Fundamental
- Price
- SIEB $2.97
- CRBU $0.84
- Analyst Decision
- SIEB
- CRBU Strong Buy
- Analyst Count
- SIEB 0
- CRBU 5
- Target Price
- SIEB N/A
- CRBU $11.80
- AVG Volume (30 Days)
- SIEB 17.5K
- CRBU 971.0K
- Earning Date
- SIEB 05-09-2025
- CRBU 03-10-2025
- Dividend Yield
- SIEB N/A
- CRBU N/A
- EPS Growth
- SIEB 57.14
- CRBU N/A
- EPS
- SIEB 0.33
- CRBU N/A
- Revenue
- SIEB $83,639,000.00
- CRBU $9,994,000.00
- Revenue This Year
- SIEB N/A
- CRBU $3.50
- Revenue Next Year
- SIEB N/A
- CRBU $177.84
- P/E Ratio
- SIEB $9.12
- CRBU N/A
- Revenue Growth
- SIEB 17.39
- CRBU N/A
- 52 Week Low
- SIEB $1.41
- CRBU $0.84
- 52 Week High
- SIEB $3.34
- CRBU $4.97
- Technical
- Relative Strength Index (RSI)
- SIEB 67.17
- CRBU 32.10
- Support Level
- SIEB $2.70
- CRBU $0.88
- Resistance Level
- SIEB $3.16
- CRBU $1.01
- Average True Range (ATR)
- SIEB 0.17
- CRBU 0.08
- MACD
- SIEB 0.07
- CRBU 0.00
- Stochastic Oscillator
- SIEB 77.38
- CRBU 2.01
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.